The Graveyard & The Winner
This category has two decades of history, and the record is unambiguous. Every venture that tried to be a listing venue for intellectual property — post assets, wait for buyers — failed, regardless of the technology attached to it. The one venture that reached institutional scale inverted the model entirely: it started from buyer demand and used the marketplace to fulfill it.
IPwe
Blockchain + AI patent marketplace with IBM as partner. Filed Chapter 11 in February 2024 with $7.2M of debt, converted to Chapter 7. Post-mortem: sellers showed up; buyers never did. The blockchain/NFT layer did not create a single buyer.
IPXI
Exchange-traded unit license rights — the most financially sophisticated attempt ever made. Closed in 2015 because licensees refused to buy licenses without a litigation threat. Efficient infringement beat the exchange.
Ocean Tomo Auctions
Live IP auctions 2006–09; peak event $23.9M. In 2009 only 6 of 81 lots sold — a 7% sell-through — under ~25% total transaction friction ($2,500/lot + 15% seller + 10% buyer premium). Auctions abandoned; firm retreated to advisory.
Scientist.com
Order-driven B2B marketplace for outsourced R&D: $3B+ cumulative procurement activity, 130+ biopharma clients (Pfizer, Sanofi, Bayer, Novartis), 6,000+ CROs, 12 private marketplaces plus the NIH, average 1.5 days from request to SOW, 16% average client savings. Acquired by GHO Capital (PE) in September 2025 — the category's biggest validation exit.
The transaction layer is graveyard territory. The order-driven services layer produced the only $B-scale winner.
Seven failure modes — and what each one teaches
- One-sided liquidity. Sellers always show up; buyers never do voluntarily (the IPwe post-mortem in one line).
- Litigation is the real marketplace. IPXI closed because licensees preferred to be sued — efficient infringement outcompeted the exchange.
- Valuation opacity. Ocean Tomo 2009: unrealistic reserve prices, 6 of 81 lots sold.
- Lemons / adverse selection. Good IP is monetized privately; public listings skew junk-heavy. Only ~21% of brokered packages ever sell; the entire brokered patent market is ~$158M/yr (Richardson Oliver, 2025).
- Transaction complexity. A patent is not a product — the reason yet2 pivoted from web marketplace to services.
- Wrong framing. Selling patents (exclusion rights) is not the same as selling solutions to problems.
- Tech theater ≠ liquidity. IPwe's blockchain and NFTs did not create one buyer.
IEM's architecture is a point-by-point answer to this list: demand first, transparent valuation, verified supply, standardized transactions, solution framing, and technology applied only where it removes cost — never as theater.
What Changed
The failure modes above were structural in 2010–2020. Four shifts since then remove the cost structure that killed every prior attempt — and they arrived together, within roughly the last three years.
LLM matching is nearly free
Function-based matching of problems to technologies — the expensive human scouting work that forced yet2 and NineSigma into services — is now performed by language models at near-zero marginal cost.
AI due diligence cost collapse
Work that priced small transactions out of existence — a $30K claim chart — now takes minutes (Patlytics). Diligence can be bundled into every transaction instead of gating it.
AI valuation is institutionalized
Algorithmic IP valuation is now institutionally accepted — LexisNexis PatentSight's Patent Asset Index, PatSnap. The "valuation opacity" that sank Ocean Tomo's auctions has a credible, machine-generated answer.
Agentic B2B commerce at $15T
Gartner projects $15 trillion of B2B purchases intermediated by AI agents by 2028. Buy-side software agents need machine-readable markets to shop in. None exists for innovation. Yet.
The IEM Model
IEM is the first AI-agent-run innovation exchange: a global order book where companies post innovation needs and innovators sell via fixed price, auction, or license slots — with instant AI valuation, agentic due diligence, and escrowed settlement built in. Two pillars, one trust layer.
SELL — three validated paths
Free listing everywhere; IEM monetizes success, verification, and data.ORDER — the innovation order book
A company posts an Innovation Order; a six-agent pipeline fulfills it end-to-end.Post a need. Our agents find, verify, price, and close.
Total published friction is ~10–15% versus 25–40% in the legacy brokered market — and every listing is machine-readable (MCP/API-first), making IEM the first innovation market built for buyer AI agents to shop in.
Competitive Landscape
The full field, from the dead exchanges to the newly funded AI workflow tools. Read the last column: capital is flowing into tools that stop short of running a marketplace.
| Player | Model | Traction | Fees | Status 2026 |
|---|---|---|---|---|
| Scientist.com | Order-driven B2B marketplace for outsourced R&D (pharma ↔ 6,000+ CROs) | $3B+ cumulative procurement activity; 130+ biopharma clients (Pfizer, Sanofi, Bayer, Novartis); 12 private marketplaces + NIH; 18M products; avg 1.5 days request→SOW; 16% avg client savings | Transaction margin + private-marketplace SaaS + compliance (COMPLi) | Acquired by GHO Capital (PE), Sept 2025 — category's biggest validation exit |
| Wazoku / InnoCentive | Challenge crowdsourcing + idea SaaS | 1M+ solvers; 2,500+ challenges, 80% success, $60M awards | Historical: $15–35K posting + up to 40% award premium; now enterprise SaaS | Active; InnoCentive itself sold 2020 for only ~$1.58M |
| yet2 | Tech scouting / OI consulting + anonymous patent buying | Pivoted from web marketplace → services | Retainer + commission | Active, services-led |
| NineSigma | Tech scouting RFP broadcasts | HQ Tokyo, 3 entities | Project fees + success commission | Active |
| IN-PART | Curated university↔industry matchmaking | 10,000+ introductions since 2014 | University subscription; free for industry | Active |
| Halo (halo.science) | Companies post R&D needs; academics submit standardized proposals | ~8,000 scientists, 2,300+ universities, 100 countries; P&G, PepsiCo, BASF, Bayer; NSF pilot; $23M raised | Corporate subscription per posting | Active — closest live analog to IEM Pillar 2 |
| HeroX | DIY prize challenges | 1M+ solver network | Success fee ~18% ≤$250K, 14% above; pay-on-success | Active |
| IAM Market | Patent listing venue | Thin | Seller listing fees | Folded into IAM platform 2023 |
| Ocean Tomo auctions | Live IP auctions 2006–09 | Peak $23.9M; 2009: 6/81 lots sold | $2,500/lot + 15% seller + 10% buyer premium (~25% friction) | Abandoned; advisory only |
| IPXI | Exchange-traded unit license rights | — | ULR contracts | Dead 2015 — licensees refused to buy without litigation threat |
| IPwe | Blockchain + AI patent marketplace (IBM partner) | — | — | Dead — Ch.11 Feb 2024 ($7.2M debt) → Ch.7; no willing buyers |
| Tynax | Patent broker + listing | 15+ yrs | Commission | Active, small |
| Wellspring / Flintbox | TTO software + express licensing | Standard for US/CA TTOs | SaaS | Active |
| Tradespace | AI-native end-to-end IP platform (disclosure → AI drafting → monetization) | "$100M+ IP commercialization revenue unlocked" (BAE, DoD) | SaaS + services | $15M Series A Jan 2026 (AVP) — closest agentic-IP competitor |
| Patlytics | AI patent workflows for law firms | 40%+ of Am Law 100 | SaaS | $40M Series B Apr 2026 (SignalFire) |
| Cypris / Findest / Iris.ai | AI tech-scouting (500M+ patents/papers, function-based search) | Enterprise R&D | SaaS | Active — find tech but don't transact |
| Perplexity Patents | Conversational AI patent search | Launched Oct 2025 | Freemium | Commoditizing search |
The structural insight: the transaction layer is graveyard territory (IPXI, IPwe, Ocean Tomo); the order-driven services layer produced the only $B-scale winner (Scientist.com); and 2024–26 capital is flowing into AI workflow tools (Tradespace, Patlytics) that stop short of running a marketplace. Nobody combines AI-agent execution with a two-pillar transactional marketplace. That is IEM's gap.
Ten game-changer differentiators
COMPETITIVE CHECK — no incumbent does ≥3 of these together.
Market
The addressable value flow is enormous and growing; the open, transactable share of it is vanishingly small. The spread between the two is the opportunity.
| Market | Size | Trajectory | Source |
|---|---|---|---|
| Cross-border IP payments | >$1 trillion (2023) | 2× since 2010, ~5.5% CAGR | WIPO / World Bank |
| Global IP licensing | ~$314–340B (2024–25) | → $580B by 2033 | Industry estimates |
| Patent licensing | ~$182.6B (2025) | → $412.8B by 2035 | Industry estimates |
| AI IP & licensing segment | $15.4B (2025) | 29.8% CAGR | Industry estimates |
| CRO / pharma R&D outsourcing | $92.3B (2025) | → $199B by 2034 | Industry estimates |
| University tech transfer (US/CA) | $3.8B licensing income / yr | ~800 new products / yr | AUTM |
| Brokered patent market (open) | ~$158M / yr | 21% sell-through | Richardson Oliver (2025) |
| Agentic B2B commerce | $15T by 2028 | Buy-side AI agents intermediating purchases | Gartner |
>$1T of value flow vs a $158M open market — a >6,000× liquidity gap. That gap is the story.
Business Model & Unit Economics
Listing is free everywhere — supply feeds the data flywheel. IEM monetizes success, verification, enterprise rails, settlement, and data. Five revenue streams:
- Success fees — 8–18% by venue. Direct sales 8–15%; auctions ~10% seller + 5% buyer premium; license slots 10–15% of upfront plus 5–10% of running royalties; Innovation Orders tiered 18/14/10% by deal size (HeroX-proven, pay-on-success), plus 5–10% margin on commissioned development.
- Verification tiers. Paid IEM Score deep verification, Tech Passport issuance, and agentic due diligence packages layered above the free baseline.
- Enterprise private order books. $50–250K/yr SaaS for a company's confidential demand channel on IEM rails — the model Scientist.com proved with 12 private marketplaces plus the NIH.
- Escrow spread. Settlement margin against the 0.89–3.25% industry benchmark (Escrow.com).
- Data & insights subscriptions. Buyer-side subscriptions at ~$4,200/yr ARPA — pricing signals, royalty comps, and demand analytics generated by the exchange itself.
Unit economics (business plan)
The Raise & Roadmap
Staged capital against staged proof. The pre-seed exists to validate one thing — that an order book for innovation clears — before venture-scale capital is committed.
Launch Pillar 2 in one vertical; fulfill early Innovation Orders with an agent stack plus human oversight (services-led, the yet2/Scientist.com starting motion). Prove the demand side before scaling supply.
Raised against Go/No-Go gate evidence. Automate the six-agent pipeline, open direct sales and license slots, ship the IEM Score and Tech Passport, land first enterprise private order books.
Expand from the beachhead vertical, open auctions where buyer density supports them, scale the machine-readable (MCP/API) surface for buyer agents. Ideal total raise across stages: $16M.
Go / No-Go gates
Demand-side pull confirmed; buyer acquisition cost within model.
The order book clears. Seed round proceeds on evidence, not narrative.
Five-year financial trajectory
Free cash flow runs from −$3.75M in Year 1 to +$19.71M in Year 5, with break-even in Year 4 and a maximum cumulative deficit of $10.74M — inside the staged raise.
Structure & strategy
- Singapore HoldCo. Singapore Pte Ltd holding company with operating subsidiaries — neutral, treaty-rich, investor-familiar. Pilots anywhere; no single home market.
- Vertical beachhead. One industry first — mining / energy / agri-tech families — per the Scientist.com lesson: it took ~10 years and vertical focus to reach $B scale. A vertical beachhead beats a horizontal launch.
- Lead with problems, not patents. Orders open the market; the sell-side follows demand. Auction liquidity is never promised before buyer density exists.
Exit Comps
Acquirers and growth investors are already circling this exact space — the comp set spans validation, caution, and fresh capital:
| Event | Year | What it says |
|---|---|---|
| GHO Capital → Scientist.com | Sept 2025 | PE acquisition of the order-driven category winner ($3B+ cumulative activity) — the model IEM generalizes. The category's biggest validation exit. |
| Wazoku → InnoCentive | 2020 | The cautionary comp: the challenge-crowdsourcing pioneer sold for only ~$1.58M. Solver networks without transaction rails don't compound value. |
| SignalFire → Patlytics, $40M Series B | Apr 2026 | Fresh growth capital into AI patent workflows (40%+ of Am Law 100) — tooling, not a marketplace. |
| AVP → Tradespace, $15M Series A | Jan 2026 | The closest agentic-IP competitor funded — end-to-end IP platform (BAE, DoD), still stops short of running an open exchange. |
The pattern: capital rewards transaction infrastructure with demand-side gravity and punishes networks without rails. IEM is built on the winning side of that line from day one.
Request the full data room
Financial model, agent-pipeline architecture, vertical beachhead analysis, gate metrics, and the Singapore structure memo — available under NDA to qualified investors.
Request the Data Room →[email protected] · IEM — The Order Book for Human Innovation